Skip to content

KL PHARMA

Active Private limited companyfounded 2009active for 17 yearsRue Couture d'Orroir 3, 7750 Mont-de-l'EnclusKBO/BCE: BE 0811.781.221

Lifetime

16 annual accounts with figures on one time axis
peak of €91,628 in 2024
€90,107▼ 1.7%
peak of €50,690 in 2025
€50,690▲ 3.4%
peak of €384,626 in 2025
€384,626▲ 15.2%
€279,902▼ 10.8%
Board2 names since 2009
2 directors and 1 other
Documentsfilings and deeds
29-06-202632 days before the deadline
2025micro format
Equity from €333,936 to €384,626

Key points

from the 2025 annual accounts

Equity

€384,626 ▲ 15.2%

KL PHARMA has made a profit in every financial year since 2010.

Turnover

≈ €210,000 estimated

The accounts state no turnover.

Filings

16 annual accounts since 2010
AprilJune31 JulyOctober2010201520202025

The last five annual accounts were filed 31 to 36 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0811781221
appointed as statutory director “texte français sous 7/c” (deed in French) · General meeting of 26-12-2022 · Gazette deed
Registered office moved from Kluisbergen to Amougies The registered office moved from 9690 Kluisbergen (Ruien) . Doveleen 2 to Rue Couture d'Omoir 3 te 7750 Amougies · General meeting of 01-04-2010 · Gazette deed
Incorporation Founded by and · Capital of €75,000, 750 shares · appointed as statutory manager · published on 27-05-2009 · Gazette deed
All 25 events

Comparable companies

same main activity, similar in size and age
Company
KL PHARMA Mont-de-l'Enclus €664,528 €90,107 57.9% -
SOMIAR Alken €676,762 €92,787 19.1% -
Lex'In Malle €588,660 €88,587 28.3% -
LAWINE Retie €758,736 €94,032 85.7% -
Attractum Tongeren-Borgloon €676,024 €98,432 61.5% -
ADRIX Sprimont €582,074 €91,462 79.5% -
HALBO INVEST Oostkamp €588,478 €90,348 86.2% -

These companies have the same main activity as KL PHARMA: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €582,000 and €759,000, founded between 2008 and 2010.

Official details

Source: KBO
Status
Active since 18-05-2009Normal situation
Activity
Activities of holding companiesNACE 64210
Establishment unit
2.178.783.0197750 Mont-de-l'Enclus, registered on 18-05-2009
Financial year end
31 December
Peppol
Reachable since 01-12-2025
Company details

Annual accounts 2025

€664,528▲ 2.6%
Filing
Filed on 29-06-2026, 32 days before the end of the filing period
Financials

Insights on KL PHARMA

KL PHARMA files the micro format. That format states no turnover. The gross margin rose from €62,145 in 2010 to €90,107 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about KL PHARMA

What is the company number of KL PHARMA?
The company number of KL PHARMA is 0811.781.221. The VAT number is the same number with BE in front: BE 0811.781.221.
Where is KL PHARMA based?
The registered office is at Rue Couture d'Orroir 3, 7750 Mont-de-l'Enclus.Company details
What does KL PHARMA do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of KL PHARMA?
KL PHARMA is a private limited company (BV).
When was KL PHARMA founded?
KL PHARMA was founded on 18-05-2009.
Is KL PHARMA still active?
Yes, KL PHARMA is an active enterprise in the KBO register.
What is the turnover of KL PHARMA?
The turnover in financial year 2025 is about €210,000. This figure is estimated from the gross margin of €90,107 and 39 comparable companies (NACE 64210). It probably lies between €130,000 and €260,000.Financials
Is KL PHARMA profitable?
In financial year 2025, KL PHARMA made a profit of €50,690.
Where can I find the annual accounts of KL PHARMA?
KL PHARMA filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of KL PHARMA due?
KL PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.